Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - ACCOUNTS PAYABLE
Accounts Payable CRVS - Corvus Pharmaceuticals, Inc.
1.52 M
LAST VALUE
-1.29%
2 YEAR CAGR
-5.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR